(Q43207795)

16 November 2017

title

Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis (English)

1 reference

16 November 2017

1 reference

Ken-Ichiro Tanaka

1

1 reference

16 November 2017

Tomoaki Ishihara

2

1 reference

16 November 2017

Arata Azuma

3

1 reference

16 November 2017

Shoji Kudoh

4

1 reference

16 November 2017

Masahito Ebina

5

1 reference

16 November 2017

Toshihiro Nukiwa

6

1 reference

16 November 2017

Yukihiko Sugiyama

7

1 reference

16 November 2017

Yuichi Tasaka

8

1 reference

16 November 2017

Takushi Namba

9

1 reference

16 November 2017

Tsutomu Ishihara

10

1 reference

16 November 2017

Keizo Sato

11

1 reference

16 November 2017

Yutaka Mizushima

12

1 reference

16 November 2017

Tohru Mizushima

13

1 reference

16 November 2017

publication date

24 December 2009

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

16 November 2017

published in

1 reference

16 November 2017

volume

298

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

L348-60

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

16 November 2017

1 reference

The role of transforming growth factor beta in lung development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Superoxide dismutase and catalase as therapeutic agents for human diseases. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Antisense oligonucleotide inhibition of heat shock protein (HSP) 47 improves bleomycin-induced pulmonary fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Therapeutic effect of lecithinized superoxide dismutase against colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Role of reactive oxygen metabolites in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Classification and natural history of the idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Murine models of pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Increased oxidative stress and altered levels of antioxidants in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Protection against bleomycin-induced lung injury by IL-18 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Pharmacokinetics of PC-SOD, a lecithinized recombinant superoxide dismutase, after single- and multiple-dose administration to healthy Japanese and Caucasian volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Pharmacokinetics of recombinant human superoxide dismutase in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Current perspectives on the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00289.2009

10.1152/AJPLUNG.00289.2009

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference